妊娠梅毒患者三剂肌注苄星青霉素G的药代动力学研究
该前瞻性药代动力学研究纳入30例妊娠期梅毒患者,接受每周一次肌注苄星青霉素G 2.4百万单位共三剂。群体药代动力学模型显示双相吸收,第二相吸收半衰期为18天;所有患者在第二剂后至少28天维持目标浓度(18 ng/mL)以上,但6例(21%)在第二剂前(第7天)出现亚治疗浓度。提示三剂方案可维持治疗浓度至少4周,单剂或两剂方案值得评估。
要点
- 三剂每周肌注苄星青霉素G在妊娠梅毒患者中可维持目标浓度至少4周
- 21%患者在第二剂前(第7天)出现亚治疗浓度
- 孕周不影响苄星青霉素G的表观清除率或分布容积
核心结论
- 三剂每周肌注苄星青霉素G方案在妊娠梅毒患者中维持治疗浓度至少4周,提示可评估更简单的单剂或两剂方案。
研究设计与样本
- 前瞻性药代动力学研究,纳入30例埃塞俄比亚妊娠梅毒患者(孕中期15例、孕晚期15例),接受三剂每周肌注苄星青霉素G(每剂2.4百万单位)。
- 干血斑样本采集至首剂后8周,液相色谱-质谱法定量苄星青霉素浓度,采用非线性混合效应模型进行群体药代动力学分析。
主要发现
- 药代动力学模型显示双相吸收,第二相吸收半衰期为18天。
- 孕周不影响表观清除率或分布容积。
- 所有患者在第二剂后至少28天维持苄星青霉素浓度高于目标阈值18 ng/mL,中位总累积时间(>18 ng/mL)为46天(四分位距41-52天)。
- 6例参与者(21%)在计划第二剂前(第7天)出现亚治疗浓度。
关键数值与推荐
- 目标阈值:苄星青霉素浓度18 ng/mL。
- 给药方案:肌注苄星青霉素G 2.4百万单位,每周一次,共三剂。
临床怎么用
- 三剂每周肌注苄星青霉素G方案在妊娠梅毒患者中可维持治疗浓度至少4周,支持评估单剂或两剂方案的药代动力学暴露和临床结局。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Syphilis remains a global public health concern, particularly in pregnancy due to the risk of congenital syphilis. The WHO recommends benzathine penicillin G (BPG) as the standard treatment in pregnant women, whilst the optimal dosing strategy has not been established, particularly in relation to the impact of gestational age. This study sought to characterize the pharmacokinetics (PK) of a three-dose regimen of intramuscular BPG, given at weekly intervals, in pregnant women with syphilis. METHODS: A prospective PK study was undertaken in 30 pregnant Ethiopian women (second (n = 15) and third (n = 15) trimester) with syphilis (late or of unknown duration) who received three, once-weekly doses of intramuscular BPG (2.4 million units per dose). Dried blood spot samples were collected for up to 8 weeks after the first dose and benzylpenicillin concentrations quantified by liquid chromatography-mass spectrometry. Population PK analysis was performed using nonlinear, mixed-effects modelling. RESULTS: The PK model demonstrated biphasic absorption with a second-phase absorption half-life of 18 days. Gestational age did not impact apparent clearance or volume of distribution. Benzylpenicillin concentrations remained above the target threshold (18 ng/mL) for at least 28 days after the second dose in all women (median total cumulative time >18 ng/mL was 46 days [interquartile range 41-52 days)]. However, six participants (21%) exhibited subtherapeutic concentrations before the scheduled second injection (Day 7). CONCLUSION: A three-dose, once-weekly intramuscular BPG regimen maintained therapeutic concentrations for at least 4 weeks, suggesting potentially simpler, single- or two-dose BPG regimens in pregnant women with syphilis should be evaluated for both PK exposure and clinical outcomes.
引用
- Birru EM, Salman S, Page-Sharp M, et al. Pharmacokinetics of a three-dose regimen of intramuscular benzathine penicillin G in pregnant women with syphilis. J Antimicrob Chemother. 2026. PMID: 42046912. doi:10.1093/jac/dkag145
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。